136 related articles for article (PubMed ID: 33247397)
21. Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers.
Kirchheiner J; Meineke I; Müller G; Bauer S; Rohde W; Meisel C; Roots I; Brockmöller J
Clin Pharmacokinet; 2004; 43(4):267-78. PubMed ID: 15005635
[TBL] [Abstract][Full Text] [Related]
22. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
[TBL] [Abstract][Full Text] [Related]
23. Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects.
Bauer M; Bamminger K; Pichler V; Weber M; Binder S; Maier-Salamon A; Tahir A; Jäger W; Haslacher H; Tournier N; Hacker M; Zeitlinger M; Langer O
Clin Pharmacol Ther; 2021 Mar; 109(3):754-761. PubMed ID: 32966590
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen.
Hu XX; Zhou Q; Lan T; Huang XX; Liang BQ; Dai DP; Cai JP; Hu GX
J Pharm Pharmacol; 2016 Jun; 68(6):819-25. PubMed ID: 27109434
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Modeling Analysis Demonstrates the Impact of CYP2C19 and CYP2D6 Genetic Polymorphisms on the Pharmacokinetics of Amitriptyline and Its Metabolite, Nortriptyline.
Koh A; Pak KC; Choi HY; Ryu S; Choi SE; Kim KS; Bae KS; Lim HS
J Clin Pharmacol; 2019 Apr; 59(4):532-540. PubMed ID: 30452773
[TBL] [Abstract][Full Text] [Related]
27. Effect of clarithromycin pre-treatment on the pharmacokinetics of metoclopramide after their simultaneous oral intake.
Kaukab I; Shah SNH; Kharaba ZJ; Buabeid MA; Alfoteih YA; Murtaza G
Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):735-740. PubMed ID: 32524862
[TBL] [Abstract][Full Text] [Related]
28. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects.
Yin OQ; Mak VW; Hu M; Fok BS; Chow MS; Tomlinson B
Eur J Clin Pharmacol; 2012 Jun; 68(6):943-9. PubMed ID: 22281720
[TBL] [Abstract][Full Text] [Related]
29. Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
Kim KA; Park IB; Park JY
Eur J Clin Pharmacol; 2018 Oct; 74(10):1281-1289. PubMed ID: 29947950
[TBL] [Abstract][Full Text] [Related]
30. Influence of Rifampicin Pre-treatment on the In vivo Pharmacokinetics of Metoclopramide in Pakistani Healthy Volunteers Following Concurrent Oral Administration.
Kaukab I; Shah SNH; Abrar MA; Anwer N; Murtaza G
Curr Drug Metab; 2020; 21(4):301-306. PubMed ID: 32407272
[TBL] [Abstract][Full Text] [Related]
31. CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta-analysis.
Zhang L; Brown SJ; Shan Y; Lee AM; Allen JD; Eum S; de Leon J; Bishop JR
Pharmacotherapy; 2020 Jul; 40(7):632-647. PubMed ID: 32519344
[TBL] [Abstract][Full Text] [Related]
32. The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.
Kuzin M; Scharrer I; Nolan D; Baumgartner M; Paulzen M; Schoretsanitis G; Xepapadakos F
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):354-357. PubMed ID: 32365274
[No Abstract] [Full Text] [Related]
33. In silico prediction of drug binding to CYP2D6: identification of a new metabolite of metoclopramide.
Yu J; Paine MJ; Maréchal JD; Kemp CA; Ward CJ; Brown S; Sutcliffe MJ; Roberts GC; Rankin EM; Wolf CR
Drug Metab Dispos; 2006 Aug; 34(8):1386-92. PubMed ID: 16698891
[TBL] [Abstract][Full Text] [Related]
34. Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers.
Kirchheiner J; Henckel HB; Meineke I; Roots I; Brockmöller J
J Clin Psychopharmacol; 2004 Dec; 24(6):647-52. PubMed ID: 15538128
[TBL] [Abstract][Full Text] [Related]
35. Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics.
Swaisland HC; Cantarini MV; Fuhr R; Holt A
Clin Pharmacokinet; 2006; 45(6):633-44. PubMed ID: 16719544
[TBL] [Abstract][Full Text] [Related]
36. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
Gan SH; Ismail R; Wan Adnan WA; Zulmi W
Mol Diagn Ther; 2007; 11(3):171-81. PubMed ID: 17570739
[TBL] [Abstract][Full Text] [Related]
37. Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro.
Hu XX; Yuan LJ; Fang P; Mao YH; Zhan YY; Li XY; Dai DP; Cai JP; Hu GX
Drug Metab Pharmacokinet; 2016 Apr; 31(2):133-8. PubMed ID: 27016952
[TBL] [Abstract][Full Text] [Related]
38. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
39. Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.
Lee CM; Kang P; Cho CK; Park HJ; Lee YJ; Bae JW; Choi CI; Kim HS; Jang CG; Lee SY
Arch Pharm Res; 2022 Jun; 45(6):433-445. PubMed ID: 35763157
[TBL] [Abstract][Full Text] [Related]
40. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.
Belmonte C; Ochoa D; Román M; Saiz-Rodríguez M; Wojnicz A; Gómez-Sánchez CI; Martín-Vílchez S; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):596-605. PubMed ID: 29325225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
